Scrip
Market Insight - How the IMI is reinvigorating European pharma research
19 January 2010
Dr David Pountney, Colin Maher and Nick Beckett
Please Login to read the full article.
19 January 2010
Dr David Pountney, Colin Maher and Nick Beckett
The Innovative Medicines Initiative (IMI) is a public-private partnership which aims to bolster Europe's competitive edge in pharmaceutical research and improve the mechanisms for bringing new medicines to the marketplace.
Dr David Pountney
,
Colin Maher
and
Nick...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Face to face: Ex-Novartis manager takes two-step approach to women's health at Lumavita
- Anti-obesity drugs: an inventor's perspective
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
